Conclusion: Compared with etomidate, ketamine probably results in more hemodynamic instability during the peri-intubation period and appears to have no effect on successful intubation on the first attempt or mortality. However, ketamine results in decreased need for the initiation of vasopressor use and decreases adrenal suppression compared with etomidate.
PubMed 39570063 ↗Ketamine
Also known as Esketamine, Spravato
The short answer. More people than not who report on Ketamine say it helped (65% of 65). It is most often used for mood: 97% of 62 reports say that improved. It is well studied — 854 meta-analyses on PubMed.
From 141 mentions in total — the rest didn't say how it went and aren't counted.
What Ketamine does, according to users
Of the people who reported each effect, the share who said it got better.
5 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 854 meta-analyses on PubMed ↗ · 1,957 randomized trials ↗
Conclusion: The study findings suggest that esketamine's efficacy as an add-on to antidepressants is modest in treatment-resistant depression (similar to augmentation strategies with atypical antipsychotics) and is absent against suicidality itself. These findings need to be considered in light of esketamine's abuse potential and the fact that long-term effects are still not fully known. Some alarming signs concerning deaths and emerging suicidality during the testing phase are discussed, along with other regulatory issues.
PubMed 39876682 ↗Conclusion: Intravenous ketamine appears to be more efficacious than intranasal esketamine for the treatment of depression.
PubMed 33022440 ↗Conclusion: Compared with placebo, NSAIDs, ketamine, and mid- to high-potency opioids are effective in reducing acute pediatric pain. NSAIDs provide the greatest benefits and least harm, suggesting that they should be the first-line therapy for acute painful conditions in children.
PubMed 39899301 ↗1,900 human trials on ClinicalTrials.gov test Ketamine — 966 completed, 212 recruiting now. See all on ClinicalTrials.gov ↗
- Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT · ECT, Depression · 2026
- Ketamine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Ultrasound Guided Bilateral Superficial Cervical Plexus Block in Thyroidectomy · Thyroidectomy, Bupivacaine · 2026
- Oral Ketamine for Treatment of Vaso-Occlusive Pain · Vaso-occlusive Crisis · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Ketamine is a Schedule III controlled substance in the US. DEA controlled-substance list ↗
The current US prescription label has no boxed warning.
42 recalls of products named for Ketamine. Most recent:
- 2026-05-06 · Class II: cGMP deviations. record ↗
- 2026-02-18 · Class II: Lack of Assurance of Sterility record ↗
- 2025-10-22 · Class III: Labeling: Incorrect or Missing Lot and/or Exp Date record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
4,846 adverse-event reports mention Ketamine. Most often reported:
- Infusion site pain · 733
- Drug ineffective · 526
- Off label use · 509
- Nausea · 503
- Infusion site erythema · 462
- Headache · 319
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Ketamine B — a highly likely cause of liver injury (12–50 published cases). LiverTox entry ↗
NIH has funded 83 research projects with Ketamine in the title, $115,871,256 in total (1985–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Ketamine Injection ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“One thing that has really helped me tremendously, without the nasty side effects of SSRIs, is Ketamine infusions.”
“killed my anxiety and elevated my mood a lot when it stopped acting...had an abnormality on my kidneys (elevated creatinine)”
“Esketamine treatment for 9 months helped me tremendously again anxiety when i was at my worst.”
“I don't know much about ketamine, but it helps my depression better than anything I've ever tried.”
Top discussions (5)
- Taurine is criminally underrated ↗
- Hello. I was severely damaged by a common medication I took 6 years and 10 months ago. ↗
- Just saw this on X: "A new study is out: things that make you age faster, and slower, according to 16 epigenetic age clocks" ↗
- This is a before and after… 7 months on Reta, BPC157, TB500, Tesa, MOTS-C, GHK-cu, Selank, Semax, and TRT, along with an intense diet. Down 110lbs. 48” waist to 27”. ↗
- Hello. About best way to taper and heal from psych meds etc? ↗
Ketamine compared
Other options for mood
Sources
- User reports: 141 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- US DEA ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate